Pioneering lab testing firm names new board member

Dave Daly’s board appointment is effective Nov. 10.


  • By
  • | 5:03 p.m. November 14, 2021
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Cancer-focused genetic testing services firm NeoGenomics has named biosciences executive Dave Daly to its board.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content